Pfizer CEO On Next Steps For Coronavirus Vaccine And His Controversial Stock Trade

Albert Bourla, head of the pharmaceutical giant, discusses plans for distributing its vaccine, which it says is 95% effective, and explains the timing of his $5.6 mllion sale of Pfizer stock.

More Headlines

Follow worldbiztoday on Twitter

US Stocks